PDIA3 and acute myeloid leukemia: It has been reported [25] that PDIA3 siRNA can effectively promote the apoptosis of AML cells and inhibit the proliferation, invasion, and migration of AML cells by regulating oxidative phosphorylation, amino sugar and nucleotide sugar metabolism pathway, and MAPK signaling pathway, thus providing a new therapeutic target for AML.